PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells

What is it about?

Cancer is one of the major causes of death worldwide. Now chemotherapeutic agents suffer from serious side effects du to encroaching on normal tissues. We present a powerful and effective targeting agent (PNC-27 peptide) to take one of the widest used anticancer drugs (Doxil) to its sit of action without compromising normal cells.

Featured Image